| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Cocrystal Pharma, Inc. (COCP) has 8 insiders with recent SEC Form 4 filings, including 10 buys and 0 sells. COCP is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 49.2K | $68.4K | - | |
| CEO | 49.2K | $68.4K | - | |
| 10% | 24.6K | $34.2K | - | |
| ? | 24.6K | $34.2K | - | |
| ? | 16.4K | $22.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Sep 1, 2016 | Wilcox Gary | Interim CEO | Buy | 10,000 | $0.41 | $4,100.00 | - | |
| Sep 1, 2016 | Schinazi Raymond F | Director, 10% Owner | Buy | 4,878,050 | $0.41 | $2,000,000.50 | New | |
| Sep 1, 2016 | Block David S | - | Buy | 10,000 | $0.41 | $4,100.00 | +6.3% | |
| Mar 15, 2016 | Meckler Jeffrey A45 | Chief Executive Officer | Buy | 294,118 | $0.51 | $150,000.18 | +81.0% | |
| Mar 15, 2016 | Rubin Steven D67 | Director | Buy | 39,216 | $0.51 | $20,000.16 | +72.2% | |
| Mar 15, 2016 | Wilcox Gary | Director | Buy | 49,020 | $0.51 | $25,000.20 | +0.3% | |
| Mar 15, 2016 | Block David S | Director | Buy | 50,000 | $0.51 | $25,500.00 | +46.0% | |
| Mar 15, 2016 | Frost Phillip Md Et Al48 | Director, 10% Owner | Buy | 2,941,177 | $0.51 | $1,500,000.27 | +2.8% | |
| Mar 15, 2016 | Hsiao Jane Ph D65 | Director | Buy | 1,235,294 | $0.51 | $629,999.94 | +56.1% | |
| Mar 15, 2016 | Schinazi Raymond F | Director, 10% Owner | Buy | 2,941,176 | $0.51 | $1,499,999.76 | +1.1% |